The diagnostic value of an anti-mu-capture immunoassay for the detection of IgM antibody against hepatitis B core antigen (anti-HBc) was evaluated. Strongly positive results were obtained from the acute phase sera of the 25 acute hepatitis B patients who were hepatitis B surface antigen (HBsAg) posi
The prevalence of “anti-HBc alone” and HBV DNA detection among anti-HBc alone in Korea
✍ Scribed by So-Young Kang; Myeong-Hee Kim; Woo-In Lee
- Publisher
- John Wiley and Sons
- Year
- 2010
- Tongue
- English
- Weight
- 80 KB
- Volume
- 82
- Category
- Article
- ISSN
- 0146-6615
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
The “anti‐HBc alone” is a frequent serological finding in clinical laboratories, making it difficult to determine whether the HBV infection has resolved. The objectives of this study were to investigate the prevalence of anti‐HBc alone and HBV DNA detection (occult HBV infection) among anti‐HBc alone, and to describe the demographic and clinical characteristics of anti‐HBc alone. A total of 17,677 sera referred from the Health Promotion Center (HPC group, 4,014 sera) as well as all the hospital clinical departments (Patient group, 13,663 sera) were tested for HBs Ag, anti‐HBc, and anti‐HBs. HBV DNA test using real‐time PCR was performed on 230 anti‐HBc alone. The prevalence of anti‐HBc alone was 8.9%, significantly higher in the Patient group than in the HPC group. The prevalence of anti‐HBc was higher in men than women and was increased with age. Very low levels of HBV DNA were found in only 4 (1.7%) out of 230 subjects with anti‐HBc alone. They were patients with conditions unrelated to chronic liver disease. Considering the high prevalence of anti‐HBc alone, the frequency of occult HBV infection among anti‐HBc alone was unexpectedly low. In addition, HBV viral load was low in these patients. Further studies are required to determine the clinical significance and infectivity of anti‐HBc alone, in conjunction with very low levels of HBV DNA and to standardize the detection methodology for both anti‐HBc alone and HBV DNA. J. Med. Virol. 82:1508–1514, 2010. © 2010 Wiley‐Liss, Inc.
📜 SIMILAR VOLUMES
## Abstract Some individuals have “occult” infection with hepatitis B virus (HBV), defined as presence of HBV genome in the serum or liver tissue without HBV surface antigen (HBsAg) in the serum. The aim of this study was to investigate whether serum antibodies against HBV core antigen in isolation
Antibodies to hepatitis B core antigen (anti-HBc) and e antigen (anti-HBe) were assayed in 46 sera from ten patients with acute hepatitis B utilizing immunoglobulin class-and subclass-specific enzyme immunoassays (EIAs). The sera were sampled 1 to 512 days after onset of hepatic symptoms. Four patie
Sera from four groups of patients with different serologic markers of HBV infection were examined for HBV DNA using molecular hybridization technique and for IgM class anti-HBc using an ELISA based on the antibody capture principle. Results of HBV DNA assay were generally in good agreement with the
Hepatitis B virus (HBV) surface antigen (HBsAg) and antibody to HBsAg (antiHBs) are excellent markers for HBV infection and its immunity. A total of 414 patients, 312 Down syndrome and 102 non-Down's syndrome, were studied, and 142 were residents of an institution (RI), whereas 272 were in nonreside
## Abstract Continuing hepatitis B virus (HBV) infection is normally associated with the presence of hepatitis B surface antigen (HBsAg) in the serum. In spite of sensitive screening assays for HBsAg, rare cases of post‐transfusion HBV infection are still observed. Antibody to hepatitis B core anti